Binge Eating Disorder Treatment Market - Global Outlook and Forecast 2021-2027

Binge Eating Disorder Treatment Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ687422 | No. of Pages: 101 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2021
This report contains market size and forecasts of Binge Eating Disorder Treatment in Global, including the following market information:
Global Binge Eating Disorder Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Binge Eating Disorder Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Binge Eating Disorder Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Binge Eating Disorder Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Binge Eating Disorder Treatment Market Segment Percentages, By Type, 2020 (%)
Medication
Services

China Binge Eating Disorder Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Binge Eating Disorder Treatment Market Segment Percentages, By Application, 2020 (%)
Hospitals
Clinics

Global Binge Eating Disorder Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Binge Eating Disorder Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Binge Eating Disorder Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Binge Eating Disorder Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Chronos Therapeutics
Shire US Inc. (part of Takeda Pharmaceutical Company)
Eli Lilly and Company
Sunovion Pharmaceuticals Inc
Promises Behavioral Health
Pyramid Healthcare (Tapestry Eating Disorder Services)
Timberline Knolls
Rosewood Centers for Eating Disorders
Walden Behavioral Care
Roche
Opiant Pharmaceuticals
Heptares
Novo Nordisk
Omeros Corp
1 Introduction to Research & Analysis Reports
    1.1 Binge Eating Disorder Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Binge Eating Disorder Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Binge Eating Disorder Treatment Overall Market Size
    2.1 Global Binge Eating Disorder Treatment Market Size: 2021 VS 2027
    2.2 Global Binge Eating Disorder Treatment Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Binge Eating Disorder Treatment Players in Global Market
    3.2 Top Global Binge Eating Disorder Treatment Companies Ranked by Revenue
    3.3 Global Binge Eating Disorder Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Binge Eating Disorder Treatment Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Binge Eating Disorder Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Binge Eating Disorder Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Binge Eating Disorder Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Binge Eating Disorder Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Binge Eating Disorder Treatment Market Size Markets, 2021 & 2027
        4.1.2 Medication
        4.1.3 Services
    4.2 By Type - Global Binge Eating Disorder Treatment Revenue & Forecasts
        4.2.1 By Type - Global Binge Eating Disorder Treatment Revenue, 2016-2021
        4.2.2 By Type - Global Binge Eating Disorder Treatment Revenue, 2022-2027
        4.2.3 By Type - Global Binge Eating Disorder Treatment Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Binge Eating Disorder Treatment Market Size, 2021 & 2027
        5.1.2 Hospitals
        5.1.3 Clinics
    5.2 By Application - Global Binge Eating Disorder Treatment Revenue & Forecasts
        5.2.1 By Application - Global Binge Eating Disorder Treatment Revenue, 2016-2021
        5.2.2 By Application - Global Binge Eating Disorder Treatment Revenue, 2022-2027
        5.2.3 By Application - Global Binge Eating Disorder Treatment Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Binge Eating Disorder Treatment Market Size, 2021 & 2027
    6.2 By Region - Global Binge Eating Disorder Treatment Revenue & Forecasts
        6.2.1 By Region - Global Binge Eating Disorder Treatment Revenue, 2016-2021
        6.2.2 By Region - Global Binge Eating Disorder Treatment Revenue, 2022-2027
        6.2.3 By Region - Global Binge Eating Disorder Treatment Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Binge Eating Disorder Treatment Revenue, 2016-2027
        6.3.2 US Binge Eating Disorder Treatment Market Size, 2016-2027
        6.3.3 Canada Binge Eating Disorder Treatment Market Size, 2016-2027
        6.3.4 Mexico Binge Eating Disorder Treatment Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Binge Eating Disorder Treatment Revenue, 2016-2027
        6.4.2 Germany Binge Eating Disorder Treatment Market Size, 2016-2027
        6.4.3 France Binge Eating Disorder Treatment Market Size, 2016-2027
        6.4.4 U.K. Binge Eating Disorder Treatment Market Size, 2016-2027
        6.4.5 Italy Binge Eating Disorder Treatment Market Size, 2016-2027
        6.4.6 Russia Binge Eating Disorder Treatment Market Size, 2016-2027
        6.4.7 Nordic Countries Binge Eating Disorder Treatment Market Size, 2016-2027
        6.4.8 Benelux Binge Eating Disorder Treatment Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Binge Eating Disorder Treatment Revenue, 2016-2027
        6.5.2 China Binge Eating Disorder Treatment Market Size, 2016-2027
        6.5.3 Japan Binge Eating Disorder Treatment Market Size, 2016-2027
        6.5.4 South Korea Binge Eating Disorder Treatment Market Size, 2016-2027
        6.5.5 Southeast Asia Binge Eating Disorder Treatment Market Size, 2016-2027
        6.5.6 India Binge Eating Disorder Treatment Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Binge Eating Disorder Treatment Revenue, 2016-2027
        6.6.2 Brazil Binge Eating Disorder Treatment Market Size, 2016-2027
        6.6.3 Argentina Binge Eating Disorder Treatment Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Binge Eating Disorder Treatment Revenue, 2016-2027
        6.7.2 Turkey Binge Eating Disorder Treatment Market Size, 2016-2027
        6.7.3 Israel Binge Eating Disorder Treatment Market Size, 2016-2027
        6.7.4 Saudi Arabia Binge Eating Disorder Treatment Market Size, 2016-2027
        6.7.5 UAE Binge Eating Disorder Treatment Market Size, 2016-2027
7 Players Profiles
    7.1 Chronos Therapeutics
        7.1.1 Chronos Therapeutics Corporate Summary
        7.1.2 Chronos Therapeutics Business Overview
        7.1.3 Chronos Therapeutics Binge Eating Disorder Treatment Major Product Offerings
        7.1.4 Chronos Therapeutics Binge Eating Disorder Treatment Revenue in Global (2016-2021)
        7.1.5 Chronos Therapeutics Key News
    7.2 Shire US Inc. (part of Takeda Pharmaceutical Company)
        7.2.1 Shire US Inc. (part of Takeda Pharmaceutical Company) Corporate Summary
        7.2.2 Shire US Inc. (part of Takeda Pharmaceutical Company) Business Overview
        7.2.3 Shire US Inc. (part of Takeda Pharmaceutical Company) Binge Eating Disorder Treatment Major Product Offerings
        7.2.4 Shire US Inc. (part of Takeda Pharmaceutical Company) Binge Eating Disorder Treatment Revenue in Global (2016-2021)
        7.2.5 Shire US Inc. (part of Takeda Pharmaceutical Company) Key News
    7.3 Eli Lilly and Company
        7.3.1 Eli Lilly and Company Corporate Summary
        7.3.2 Eli Lilly and Company Business Overview
        7.3.3 Eli Lilly and Company Binge Eating Disorder Treatment Major Product Offerings
        7.3.4 Eli Lilly and Company Binge Eating Disorder Treatment Revenue in Global (2016-2021)
        7.3.5 Eli Lilly and Company Key News
    7.4 Sunovion Pharmaceuticals Inc
        7.4.1 Sunovion Pharmaceuticals Inc Corporate Summary
        7.4.2 Sunovion Pharmaceuticals Inc Business Overview
        7.4.3 Sunovion Pharmaceuticals Inc Binge Eating Disorder Treatment Major Product Offerings
        7.4.4 Sunovion Pharmaceuticals Inc Binge Eating Disorder Treatment Revenue in Global (2016-2021)
        7.4.5 Sunovion Pharmaceuticals Inc Key News
    7.5 Promises Behavioral Health
        7.5.1 Promises Behavioral Health Corporate Summary
        7.5.2 Promises Behavioral Health Business Overview
        7.5.3 Promises Behavioral Health Binge Eating Disorder Treatment Major Product Offerings
        7.5.4 Promises Behavioral Health Binge Eating Disorder Treatment Revenue in Global (2016-2021)
        7.5.5 Promises Behavioral Health Key News
    7.6 Pyramid Healthcare (Tapestry Eating Disorder Services)
        7.6.1 Pyramid Healthcare (Tapestry Eating Disorder Services) Corporate Summary
        7.6.2 Pyramid Healthcare (Tapestry Eating Disorder Services) Business Overview
        7.6.3 Pyramid Healthcare (Tapestry Eating Disorder Services) Binge Eating Disorder Treatment Major Product Offerings
        7.6.4 Pyramid Healthcare (Tapestry Eating Disorder Services) Binge Eating Disorder Treatment Revenue in Global (2016-2021)
        7.6.5 Pyramid Healthcare (Tapestry Eating Disorder Services) Key News
    7.7 Timberline Knolls
        7.7.1 Timberline Knolls Corporate Summary
        7.7.2 Timberline Knolls Business Overview
        7.7.3 Timberline Knolls Binge Eating Disorder Treatment Major Product Offerings
        7.4.4 Timberline Knolls Binge Eating Disorder Treatment Revenue in Global (2016-2021)
        7.7.5 Timberline Knolls Key News
    7.8 Rosewood Centers for Eating Disorders
        7.8.1 Rosewood Centers for Eating Disorders Corporate Summary
        7.8.2 Rosewood Centers for Eating Disorders Business Overview
        7.8.3 Rosewood Centers for Eating Disorders Binge Eating Disorder Treatment Major Product Offerings
        7.8.4 Rosewood Centers for Eating Disorders Binge Eating Disorder Treatment Revenue in Global (2016-2021)
        7.8.5 Rosewood Centers for Eating Disorders Key News
    7.9 Walden Behavioral Care
        7.9.1 Walden Behavioral Care Corporate Summary
        7.9.2 Walden Behavioral Care Business Overview
        7.9.3 Walden Behavioral Care Binge Eating Disorder Treatment Major Product Offerings
        7.9.4 Walden Behavioral Care Binge Eating Disorder Treatment Revenue in Global (2016-2021)
        7.9.5 Walden Behavioral Care Key News
    7.10 Roche
        7.10.1 Roche Corporate Summary
        7.10.2 Roche Business Overview
        7.10.3 Roche Binge Eating Disorder Treatment Major Product Offerings
        7.10.4 Roche Binge Eating Disorder Treatment Revenue in Global (2016-2021)
        7.10.5 Roche Key News
    7.11 Opiant Pharmaceuticals
        7.11.1 Opiant Pharmaceuticals Corporate Summary
        7.11.2 Opiant Pharmaceuticals Business Overview
        7.11.3 Opiant Pharmaceuticals Binge Eating Disorder Treatment Major Product Offerings
        7.11.4 Opiant Pharmaceuticals Binge Eating Disorder Treatment Revenue in Global (2016-2021)
        7.11.5 Opiant Pharmaceuticals Key News
    7.12 Heptares
        7.12.1 Heptares Corporate Summary
        7.12.2 Heptares Business Overview
        7.12.3 Heptares Binge Eating Disorder Treatment Major Product Offerings
        7.12.4 Heptares Binge Eating Disorder Treatment Revenue in Global (2016-2021)
        7.12.5 Heptares Key News
    7.13 Novo Nordisk
        7.13.1 Novo Nordisk Corporate Summary
        7.13.2 Novo Nordisk Business Overview
        7.13.3 Novo Nordisk Binge Eating Disorder Treatment Major Product Offerings
        7.13.4 Novo Nordisk Binge Eating Disorder Treatment Revenue in Global (2016-2021)
        7.13.5 Novo Nordisk Key News
    7.14 Omeros Corp
        7.14.1 Omeros Corp Corporate Summary
        7.14.2 Omeros Corp Business Overview
        7.14.3 Omeros Corp Binge Eating Disorder Treatment Major Product Offerings
        7.14.4 Omeros Corp Binge Eating Disorder Treatment Revenue in Global (2016-2021)
        7.14.5 Omeros Corp Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer


List of Tables and Figures
Ask Sample Report to get more details…

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com